FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011011396> ?p ?o ?g. }

• W3011011396 endingPage "1290" @default.
• W3011011396 startingPage "1290" @default.
• W3011011396 abstract "The addictive nature of nicotine is likely the most significant reason for the continued prevalence of tobacco smoking despite the widespread reports of its negative health effects. Nicotine vaccines are an alternative to the currently available smoking cessation treatments, which have limited efficacy. However, the nicotine hapten is non-immunogenic, and successful vaccine formulations to treat nicotine addiction require both effective adjuvants and delivery systems. The immunomodulatory properties of short, non-natural peptide sequences not found in human systems and their ability to improve vaccine efficacy continue to be reported. The aim of this study was to determine if small “non-natural peptides,” as part of a conjugate nicotine vaccine, could improve immune responses. Four peptides were synthesized via solid phase methodology, purified, and characterized. Ex vivo plasma stability studies using RP-HPLC confirmed that the peptides were not subject to proteolytic degradation. The peptides were formulated into conjugate nicotine vaccine candidates along with a bacterial derived adjuvant vaccine delivery system and chitosan as a stabilizing compound. Formulations were tested in vitro in a dendritic cell line to determine the combination that would elicit the greatest 1L-1β response using ELISAs. Three of the peptides were able to enhance the cytokine response above that induced by the adjuvant delivery system alone. In vivo vaccination studies in BALB/c mice demonstrated that the best immune response, as measured by nicotine-specific antibody levels, was elicited from the conjugate vaccine structure, which included the peptide, as well as the other components. Isotype analyses highlighted that the peptide was able to shift immune response toward being more humorally dominant. Overall, the results have implications for the use of non-natural peptides as adjuvants not only for the development of a nicotine vaccine but also for use with other addictive substances and conventional vaccination targets as well." @default.
• W3011011396 created "2020-03-23" @default.
• W3011011396 creator A5000194618 @default.
• W3011011396 creator A5003885930 @default.
• W3011011396 creator A5005503205 @default.
• W3011011396 creator A5017186738 @default.
• W3011011396 creator A5021848268 @default.
• W3011011396 creator A5023630555 @default.
• W3011011396 creator A5029032552 @default.
• W3011011396 creator A5053178517 @default.
• W3011011396 creator A5062580125 @default.
• W3011011396 creator A5067620218 @default.
• W3011011396 date "2020-03-12" @default.
• W3011011396 modified "2023-10-01" @default.
• W3011011396 title "Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small “Non-Natural” Peptides" @default.
• W3011011396 cites W1529674879 @default.
• W3011011396 cites W1594390190 @default.
• W3011011396 cites W1596376754 @default.
• W3011011396 cites W1965276187 @default.
• W3011011396 cites W1992450378 @default.
• W3011011396 cites W1998874973 @default.
• W3011011396 cites W1999545669 @default.
• W3011011396 cites W2053793335 @default.
• W3011011396 cites W2054003563 @default.
• W3011011396 cites W2054400147 @default.
• W3011011396 cites W2065444311 @default.
• W3011011396 cites W2067914895 @default.
• W3011011396 cites W2078963930 @default.
• W3011011396 cites W2111778824 @default.
• W3011011396 cites W2141335473 @default.
• W3011011396 cites W2141342965 @default.
• W3011011396 cites W2155510706 @default.
• W3011011396 cites W2163556213 @default.
• W3011011396 cites W2165275387 @default.
• W3011011396 cites W2166436925 @default.
• W3011011396 cites W2167398285 @default.
• W3011011396 cites W2515564706 @default.
• W3011011396 cites W2530202933 @default.
• W3011011396 cites W2559918261 @default.
• W3011011396 cites W2615693364 @default.
• W3011011396 cites W2616124434 @default.
• W3011011396 cites W2656506499 @default.
• W3011011396 cites W2724823461 @default.
• W3011011396 cites W2770628447 @default.
• W3011011396 cites W2774262886 @default.
• W3011011396 cites W2801952436 @default.
• W3011011396 cites W2802297868 @default.
• W3011011396 cites W2890854864 @default.
• W3011011396 cites W2893164204 @default.
• W3011011396 cites W2893909870 @default.
• W3011011396 cites W2912889239 @default.
• W3011011396 cites W2920264076 @default.
• W3011011396 cites W2920585211 @default.
• W3011011396 cites W2969458933 @default.
• W3011011396 cites W2971400183 @default.
• W3011011396 doi "https://doi.org/10.3390/molecules25061290" @default.
• W3011011396 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7143940" @default.
• W3011011396 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32178357" @default.
• W3011011396 hasPublicationYear "2020" @default.
• W3011011396 type Work @default.
• W3011011396 sameAs 3011011396 @default.
• W3011011396 citedByCount "2" @default.
• W3011011396 countsByYear W30110113962021 @default.
• W3011011396 crossrefType "journal-article" @default.
• W3011011396 hasAuthorship W3011011396A5000194618 @default.
• W3011011396 hasAuthorship W3011011396A5003885930 @default.
• W3011011396 hasAuthorship W3011011396A5005503205 @default.
• W3011011396 hasAuthorship W3011011396A5017186738 @default.
• W3011011396 hasAuthorship W3011011396A5021848268 @default.
• W3011011396 hasAuthorship W3011011396A5023630555 @default.
• W3011011396 hasAuthorship W3011011396A5029032552 @default.
• W3011011396 hasAuthorship W3011011396A5053178517 @default.
• W3011011396 hasAuthorship W3011011396A5062580125 @default.
• W3011011396 hasAuthorship W3011011396A5067620218 @default.
• W3011011396 hasBestOaLocation W30110113961 @default.
• W3011011396 hasConcept C126322002 @default.
• W3011011396 hasConcept C134306372 @default.
• W3011011396 hasConcept C150903083 @default.
• W3011011396 hasConcept C159654299 @default.
• W3011011396 hasConcept C195616568 @default.
• W3011011396 hasConcept C197336794 @default.
• W3011011396 hasConcept C203014093 @default.
• W3011011396 hasConcept C207001950 @default.
• W3011011396 hasConcept C22070199 @default.
• W3011011396 hasConcept C2776789287 @default.
• W3011011396 hasConcept C2777863537 @default.
• W3011011396 hasConcept C2779281246 @default.
• W3011011396 hasConcept C2779547902 @default.
• W3011011396 hasConcept C2780868878 @default.
• W3011011396 hasConcept C33923547 @default.
• W3011011396 hasConcept C55493867 @default.
• W3011011396 hasConcept C71924100 @default.
• W3011011396 hasConcept C86803240 @default.
• W3011011396 hasConcept C8891405 @default.
• W3011011396 hasConcept C98274493 @default.
• W3011011396 hasConceptScore W3011011396C126322002 @default.
• W3011011396 hasConceptScore W3011011396C134306372 @default.
• W3011011396 hasConceptScore W3011011396C150903083 @default.

• next